Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 25, 2011

View Archived Issues

Sunnybrook Health Sciences and sanofi-aventis to develop vasculotide

AR-42 displays potent antitumor effects in models of embryonal carcinoma

BMS-936558 shows promise in RCC and mCRPC in phase I trial

Combined GWAS meta-analysis reveals shared genetic risk loci for Crohn's disease and celiac disease

Epidermal growth factor receptor may be marker of progression of penile squamous cancer

CD151 antigen is a marker of prostate cancer recurrence after radical prostatectomy

Vertex reports clinical data on ivacaftor in cystic fibrosis

Enrollment complete in translational clinical study of Reolysin in metastatic colorectal cancer

Bayer and Onyx begin enrollment in phase III Nexavar trial in advanced breast cancer

Evolva demonstrates preclinical efficacy of EV-077 in influenza

FDA approves OraQuick HCV Rapid Antibody Test

Endpoints met in phase Ib trial of TransPharma's ViaDor-GLP-1 agonist in type 2 diabetes

Novo Nordisk submits BLA to FDA for rFXIII in FXIII deficiency

FDA approves label update for Onglyza

NPS Pharma gives product pipeline update

IRM discloses new inhibitors of tyrosine-protein kinase SYK

Merck & Co. discloses new inhibitors of HCV serine protease NS3

Takeda submits NDA to FDA for azilsartan medoxomil plus chlorthalidone

Pharmaxis launches Aridol test kit in U.S. for bronchial hyperresponsiveness

Novartis claims new inhibitors of cyclin-dependent kinase 9

NV Organon patents new glycoprotein hormone FSH receptor agonists

Salix provides update on Xifaxan sNDA for non-constipation-predominant IBS and IBS-related bloating

Ascendis Pharma divulges new prodrugs of pramipexole

Trevena begins phase II TRV-120027 trial in acute heart failure

Isis reports phase I data on C-reactive protein inhibitor ISIS-CRPRx

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
More than two to tango: multispecifics at ESMO TAT
BioWorld Science
Multispecifics took center stage at this year’s ESMO TAT, emerging as one of the hottest trends in oncology research. Unlike traditional small-molecule drugs or...